The Global Landscape of SARS-CoV-2 Genomes, Variants, and Haplotypes in 2019nCoVR.

Genomics Proteomics Bioinformatics

China National Center for Bioinformation, Beijing 100101, China; National Genomics Data Center, Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing 100101, China; CAS Key Laboratory of Genome Sciences and Information, Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing 100101, China; University of Chinese Academy of Sciences, Beijing 100049, China. Electronic address:

Published: December 2020

AI Article Synopsis

  • China National Center for Bioinformation (CNCB) launched the 2019 Novel Coronavirus Resource (2019nCoVR) on January 22, 2020, as an open-access platform providing comprehensive sequence and clinical data for SARS-CoV-2.
  • The resource includes detailed statistics and quality evaluations of all SARS-CoV-2 isolates, allowing researchers to visualize genomic variations and track their evolution over time through historical haplotype maps.
  • Additionally, 2019nCoVR aggregates relevant literature and supports data submissions, ensuring daily updates to aid the global research community in understanding COVID-19.

Article Abstract

On January 22, 2020, China National Center for Bioinformation (CNCB) released the 2019 Novel Coronavirus Resource (2019nCoVR), an open-access information resource for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). 2019nCoVR features a comprehensive integration of sequence and clinical information for all publicly available SARS-CoV-2 isolates, which are manually curated with value-added annotations and quality evaluated by an automated in-house pipeline. Of particular note, 2019nCoVR offers systematic analyses to generate a dynamic landscape of SARS-CoV-2 genomic variations at a global scale. It provides all identified variants and their detailed statistics for each virus isolate, and congregates the quality score, functional annotation, and population frequency for each variant. Spatiotemporal change for each variant can be visualized and historical viral haplotype network maps for the course of the outbreak are also generated based on all complete and high-quality genomes available. Moreover, 2019nCoVR provides a full collection of SARS-CoV-2 relevant literature on the coronavirus disease 2019 (COVID-19), including published papers from PubMed as well as preprints from services such as bioRxiv and medRxiv through Europe PMC. Furthermore, by linking with relevant databases in CNCB, 2019nCoVR offers data submission services for raw sequence reads and assembled genomes, and data sharing with NCBI. Collectively, SARS-CoV-2 is updated daily to collect the latest information on genome sequences, variants, haplotypes, and literature for a timely reflection, making 2019nCoVR a valuable resource for the global research community. 2019nCoVR is accessible at https://bigd.big.ac.cn/ncov/.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836967PMC
http://dx.doi.org/10.1016/j.gpb.2020.09.001DOI Listing

Publication Analysis

Top Keywords

landscape sars-cov-2
8
variants haplotypes
8
2019ncovr
8
2019ncovr offers
8
sars-cov-2
6
global landscape
4
sars-cov-2 genomes
4
genomes variants
4
haplotypes 2019ncovr
4
2019ncovr january
4

Similar Publications

Since the severe acute respiratory syndrome outbreak in 2003, China has invested substantial efforts in promoting scientific and technological advances for medical countermeasures against high-threat pathogens. The examination of China's landscape identifies progress and gaps in research and development (R&D) and also highlights management and regulatory issues that should be of concern to other countries. Our study examined the current state of R&D of medical countermeasures in China during 1990-2022.

View Article and Find Full Text PDF

COVID-19 is characterized by systemic pro-inflammatory shifts with the development of serious alterations in the functioning of the immune system. Investigations of the gene expression changes accompanying the infection state provide insight into the molecular and cellular processes depending on the sickness severity and virus variants. Severe Delta COVID-19 has been characterized by the appearance of a monocyte subset enriched for proinflammatory gene expression signatures and a shift in ligand-receptor interactions.

View Article and Find Full Text PDF

The persistence of SARS-CoV-2 infections at a global level reflects the repeated emergence of variant strains encoding unique constellations of mutations. These variants have been generated principally because of a dynamic host immune landscape, the countermeasures deployed to combat disease, and selection for enhanced infection of the upper airway and respiratory transmission. The resulting viral diversity creates a challenge for vaccination efforts to maintain efficacy, especially regarding humoral aspects of protection.

View Article and Find Full Text PDF

Global Research on Cyberchondria: Scientometric and Visual Analysis From 2003 to 2022.

Stress Health

February 2025

Department of Public Health, Faculty of Medicine, Çanakkale Onsekiz Mart University, Çanakkale, Türkiye.

This study aims to summarise the research themes, hotspots, and boundaries in the field of cyberchondria using scientometrics and visual analysis methods. Until 31 December 2022, 181 publications (165 articles, 16 reviews) were identified under the topic of 'cyberchondria' in the Web of Science Core Collection database. VOSviewer was used for analysis.

View Article and Find Full Text PDF

Amidst the ongoing global challenge of the SARS-CoV-2 pandemic, the quest for effective antiviral medications remains paramount. This comprehensive review delves into the dynamic landscape of FDA-approved medications repurposed for COVID-19, categorized as antiviral and non-antiviral agents. Our focus extends beyond conventional narratives, encompassing vaccination targets, repurposing efficacy, clinical studies, innovative treatment modalities, and future outlooks.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!